BioNTech SE (BNTX)
94.89
+4.35
(+4.80%)
USD |
NASDAQ |
Mar 17, 16:00
94.50
-0.39
(-0.41%)
After-Hours: 20:00
BioNTech EPS Diluted (Quarterly) : -1.448 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GSK Plc | 0.414 |
| Merck & Co., Inc. | 1.191 |
| Novavax, Inc. | 0.1061 |
| Novo Nordisk A/S | 0.9419 |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -355.00M |
| Revenue (Quarterly) | 1.056B |
| Total Expenses (Quarterly) | 1.411B |
| Enterprise Value | 5.604B |
| Gross Profit Margin (Quarterly) | 63.27% |
| Profit Margin (Quarterly) | -33.61% |
| Earnings Yield | -5.51% |
| Normalized Earnings Yield | -3.159 |